[{"id":"437a0b30-c17c-4f59-99bc-c3201c096d92","acronym":"","url":"https://clinicaltrials.gov/study/NCT05830097","created_at":"2023-04-26T14:04:47.548Z","updated_at":"2024-07-02T16:35:26.556Z","phase":"Phase 1/2","brief_title":"A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05830097","lead_sponsor":"Coherent Biopharma (Hefei) Co., Ltd.","biomarkers":" FOLR1 • TRPV6","pipe":"","alterations":" ","tags":["FOLR1 • TRPV6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CBP-1019"],"overall_status":"Recruiting","enrollment":" Enrollment 260","initiation":"Initiation: 03/14/2023","start_date":" 03/14/2023","primary_txt":" Primary completion: 06/30/2025","primary_completion_date":" 06/30/2025","study_txt":" Completion: 09/30/2025","study_completion_date":" 09/30/2025","last_update_posted":"2023-12-12"}]